Literature DB >> 29615426

Is aldosteronism really a relatively common cause of hypertension?

Günther Egidi1, Guido Schmiemann2, Klaus Gebhardt3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29615426      PMCID： PMC5880651          DOI： 10.1503/cmaj.68999

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

2.  Prevalence of hyperaldosteronism in primary care patients with resistant hypertension.

Authors:  Guido Schmiemann; Klaus Gebhardt; Eva Hummers-Pradier; Günther Egidi
Journal:  J Am Board Fam Med       Date:  2012 Jan-Feb       Impact factor: 2.657

Review 3.  Spironolactone for hypertension.

Authors:  Josh Batterink; Sarah N Stabler; Aaron M Tejani; Curt T Fowkes
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

4.  Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.

Authors:  K C Loh; E S Koay; M C Khaw; S C Emmanuel; W F Young
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

6.  Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.

Authors:  Roberto Fogari; Paola Preti; Annalisa Zoppi; Andrea Rinaldi; Elena Fogari; Amedeo Mugellini
Journal:  Hypertens Res       Date:  2007-02       Impact factor: 3.872

7.  Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Authors:  Sabine C Käyser; Jaap Deinum; Wim Jc de Grauw; Bianca Wm Schalk; Hans Jhj Bor; Jacques Wm Lenders; Tjard R Schermer; Marion Cj Biermans
Journal:  Br J Gen Pract       Date:  2018-01-15       Impact factor: 5.386
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.